Cross-referencing clinical data
A pairing appears on this page only when a trial gave both ingredients together and measured the result. Cichoric acid has none that clears that bar.
Stitching two separate single-ingredient studies into a pairing is the one thing this engine will not do. When a study of the combination itself holds up at source, it lands here with its citation.
No invented synergy. Where actives were studied on their own rather than together, the record shows each on its own evidence, never a combined effect no trial measured.
Research strength. Research strength says how much work stands behind the combination. It is never a product score.
Independent record. Every finding is cited to a named trial, dated, and never written by the brand.
20 pairings are live across the library today. Checked 20 July 2026.
No study gave these as a pair, so they are not in the card above. But the reason they belong together is settled biochemistry, not a guess, so it is worth knowing.
Most commercial Echinacea purpurea extracts state a cichoric acid percentage on the label, so the two are not independent ingredients so much as a whole and one of its parts. Echinacea also contains alkylamides and polysaccharides with quite different behaviour. Attributing an Echinacea effect to cichoric acid alone is not supported by the composition of the products actually studied.
The two catechol groups on cichoric acid make it prone to oxidation, and stability is the main practical problem in Echinacea products. Ascorbate holds it in reduced form during processing and in the gut. This is a stability effect, documented in formulation work rather than in a human absorption trial. It has no bearing on any claimed activity beyond keeping the molecule intact.
Chicory root inulin products carry residual caffeic acid derivatives including cichoric acid unless the purification is aggressive. The two act on entirely different systems, inulin as a fermentable fibre and cichoric acid as a polyphenol. Their co-occurrence is botanical, not mechanistic. Highly purified inulin will have very little cichoric acid left.
Cichoric acid's tartaric ester bonds are hydrolysed by plant and gut esterases, releasing caffeic acid. Compounds that alter that hydrolysis change what actually reaches circulation. Thiol compounds have been examined in this context in vitro. The evidence is preclinical and the practical relevance is unknown.
Caffeic acid derivatives and flavonols compete for sulfotransferase and UDP-glucuronosyltransferase capacity in the enterocyte. At high combined polyphenol intake that competition can raise circulating levels of both. This is standard polyphenol pharmacokinetics rather than a specific cichoric acid finding, and it cuts both ways depending on which compound is in excess.
Nothing specific on file for Cichoric acid. Match the label to the daily amount above, and tell your doctor what you take.
Not medical advice. Show the label to your pharmacist.These are the studies our verdict leans on, chosen from the 4 we read for Cichoric acid. The full linked list is below.
FDA Disclaimer: These statements have not been evaluated by the Food and Drug Administration. This information is for educational purposes only and is not intended to diagnose, treat, cure, or prevent any disease. Consult your healthcare provider before starting any supplement regimen.